view article
Figure 4
Molecular structures of (I) 3-aminoquinoline; (II) 3-amino-5-mercapto-1,2,4-triazole; (III) thymoquinone; (IV) bergapten; (V) 2-hydroxy-N-[3(5)-pyrazolyl]-1,4-naphthoquinone-4-imine; (VI) 5-methyl-2-[(2-nitro-4-methylphenyl)amino]-3-thiophenecarbonitrile (orange and dark-red polymorphs); (VII) dapsone; (VIII) 2-ethoxybenzamide; (IX) 4,4′-difluorobenzyl; (X) L-α-methyldopa; (XI) 1,3-diphenoxybenzene; (XII) tetrathiafulvalene chloranil (black polymorph); (XIII) levofloxacin (anhydrous); (XIV) 4-hydroxybenzoic phenylpyridine 1:1 co-crystal; (XV) norfloxacinium saccharinate; (XVI) drofenine hydrochloride; and (XVII) S-ibuprofen. Torsional degrees of freedom are indicated with arrows.

Journal logoJOURNAL OF
APPLIED
CRYSTALLOGRAPHY
ISSN: 1600-5767
Volume 50| Part 1| February 2017| Pages 293-303
https://doi.org/10.1107/S160057671601846X
Follow J. Appl. Cryst.
Sign up for e-alerts
E-alerts
Follow J. Appl. Cryst. on Twitter
Twitter
Follow us on facebook
Facebook
Sign up for RSS feeds
RSS